Vekselberg's Long Shadow: Sanctions Against Russian Oligarch Impact Swiss Firm

The NZZ am Sonntag delves into the complex and damaging entanglement of Swiss industry with Russian oligarch Viktor Vekselberg. Medmix, a prominent Swiss company and a spin-off of the respected Sulzer group, finds itself ensnared by sanctions imposed on its major shareholder, Vekselberg. Despite the passage of time since initial US sanctions, the association continues to cast a long shadow, impacting business operations and leading to costly legal battles. The recent Polish court ruling, ordering Medmix to pay a substantial sum to a former buyer, exemplifies the persistent financial and operational risks. This case is not isolated; other Swiss firms like Sulzer and Oerlikon, which also have ties to Vekselberg's holding companies, face similar vulnerabilities. The article underscores how international sanctions, even years later, continue to disrupt and penalize Swiss businesses through their association with sanctioned individuals, creating a challenging environment for international trade and investment.